About
Day One Biopharmaceuticals Inc (NASDAQ:DAWN) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 6 2026
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
Feb 24 2026
Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance
Feb 10 2026
Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026
Jan 11 2026
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
Jan 6 2026
Day One Completes Acquisition of Mersana Therapeutics
Translate